| Identification | Back Directory | [Name]
N6-2-(4-AMINOPHENYL)ETHYL-ADENOSINE | [CAS]
89705-21-5 | [Synonyms]
Adenosine, N-[2-(4-aminophenyl)ethyl]-
N6-2-(4-AMINOPHENYL)ETHYLADENOSINE (APNE A) ADENOSINE, N6-2-(4-AM
Adenosine, N6-2-(4-aminophenyl)ethyl, APNEA, N-[2-(4-Aminophenyl)ethyl]-adenosine
N6-2-(4-Aminophenyl)ethyladenosine,APNEA, Adenosine, N6-2-(4-aminophenyl)ethyl, N-[2-(4-Aminophenyl)ethyl]-adenosine | [Molecular Formula]
C18H22N6O4 | [MDL Number]
MFCD00211351 | [MOL File]
89705-21-5.mol | [Molecular Weight]
386.41 |
| Chemical Properties | Back Directory | [Boiling point ]
781.8±70.0 °C(Predicted) | [density ]
1.65±0.1 g/cm3(Predicted) | [storage temp. ]
2-8°C | [solubility ]
methanol: 0.2 mg/mL, slightly soluble | [form ]
Solid | [pka]
13.12±0.70(Predicted) | [color ]
Off-white to light brown |
| Hazard Information | Back Directory | [Uses]
N6-2-(4-Aminophenyl)ethyladenosine is an adenosine receptor agonist. | [Biological Activity]
Potentnon-selective A3 adenosine receptor agonist. | [in vivo]
APNEA (N6-[2-(4-Aminophenyl)ethyl]adenosine; 2-4 mg/kg) has no significant effect on seizure parameters (seizure severity, seizure duration and afterdischarge duration) in amygdala-kindled rats. N6-[2-(4-Aminophenyl)ethyl]adenosine is combined with antiepileptic drugs administered at doses ineffective in fully kindled rats[1]. | [storage]
Store at -20°C |
|
| Company Name: |
NewCan Biotech Limited
|
| Telephone: |
+86-571-86912261 19975279805 |
| Website: |
https://www.newcanbio.com/ |
| Company Name: |
cjbscvictory
|
| Telephone: |
13348960310 13348960310 |
| Website: |
www.weikeqi-biotech.com/ |
| Company Name: |
ChemeGen
|
| Telephone: |
18818260767 |
| Website: |
https://www.chemegen.com |
| Company Name: |
Bide Pharmatech Ltd.
|
| Telephone: |
400-1647117 13681763483 |
| Website: |
https://www.bidepharm.com/ |
|